Clinical Trial Update: A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) [Phase 4]

View source ↗

Summary

Post-marketing Phase 4 real-world evidence study to evaluate the safety of Desidustat for treating anemia in chronic kidney disease patients; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• Desidustat (Desidustat)

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Chronic Kidney Diseases, Anemia of Chronic Kidney Disease | Phase 4 | Status: RECRUITING